Obesity Prevalence Among U.S. Adults During the COVID-19 Pandemic
Published by Elsevier Inc..
INTRODUCTION: As the COVID-19 pandemic unfolded, several studies collected small and relatively homogenous samples to track U.S. adult obesity rates and obesity-related risk factors. In this study, a much larger sample from a nationally representative survey was used to investigate changes in average BMI, obesity prevalence rates, and 4 obesity-related risk factors in the U.S. adult population during the COVID-19 pandemic.
METHODS: Using a large nationally representative sample of U.S. adults aged ≥20 years from the 2011-2020 Behavioral Risk Factor Surveillance System, linear regression models estimated intra-pandemic changes in average BMI and obesity prevalence rates as well as 4 obesity-related risk factors.
RESULTS: Relative to the 2019 to prepandemic 2020 period, significantly higher average BMI (+0.6%, p<0.05, N=3,555,865) and obesity prevalence rates (+3%, p<0.05, N=3,555,865) were observed among U.S. adults during the COVID-19 pandemic. Significantly higher rates of any exercise participation (+4.4%, p<0.01, N=3,607,272), average sleep hours in a 24-hour period (+1.5%, p<0.01, N=1,907,798), average alcoholic drink days in the past month (+2.7%, p<0.05, N=3,577,090), and lower rates of smoking at least some days (-4%, p<0.01, N=3,625,180) were also observed.
CONCLUSIONS: During the COVID-19 pandemic, U.S. adult obesity rates were higher and worsened the pre-existing epidemic of adult obesity in the U.S. Higher rates of alcohol consumption and lower smoking rates may have contributed to the higher rates of adult obesity in the U.S during the COVID-19 pandemic.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:63 |
|---|---|
| Enthalten in: |
American journal of preventive medicine - 63(2022), 1 vom: 20. Juli, Seite 102-106 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Restrepo, Brandon J [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 22.06.2022 Date Revised 16.07.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.amepre.2022.01.012 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM342463551 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM342463551 | ||
| 003 | DE-627 | ||
| 005 | 20231226014155.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.amepre.2022.01.012 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1141.xml |
| 035 | |a (DE-627)NLM342463551 | ||
| 035 | |a (NLM)35725124 | ||
| 035 | |a (PII)S0749-3797(22)00095-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Restrepo, Brandon J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Obesity Prevalence Among U.S. Adults During the COVID-19 Pandemic |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.06.2022 | ||
| 500 | |a Date Revised 16.07.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Published by Elsevier Inc. | ||
| 520 | |a INTRODUCTION: As the COVID-19 pandemic unfolded, several studies collected small and relatively homogenous samples to track U.S. adult obesity rates and obesity-related risk factors. In this study, a much larger sample from a nationally representative survey was used to investigate changes in average BMI, obesity prevalence rates, and 4 obesity-related risk factors in the U.S. adult population during the COVID-19 pandemic | ||
| 520 | |a METHODS: Using a large nationally representative sample of U.S. adults aged ≥20 years from the 2011-2020 Behavioral Risk Factor Surveillance System, linear regression models estimated intra-pandemic changes in average BMI and obesity prevalence rates as well as 4 obesity-related risk factors | ||
| 520 | |a RESULTS: Relative to the 2019 to prepandemic 2020 period, significantly higher average BMI (+0.6%, p<0.05, N=3,555,865) and obesity prevalence rates (+3%, p<0.05, N=3,555,865) were observed among U.S. adults during the COVID-19 pandemic. Significantly higher rates of any exercise participation (+4.4%, p<0.01, N=3,607,272), average sleep hours in a 24-hour period (+1.5%, p<0.01, N=1,907,798), average alcoholic drink days in the past month (+2.7%, p<0.05, N=3,577,090), and lower rates of smoking at least some days (-4%, p<0.01, N=3,625,180) were also observed | ||
| 520 | |a CONCLUSIONS: During the COVID-19 pandemic, U.S. adult obesity rates were higher and worsened the pre-existing epidemic of adult obesity in the U.S. Higher rates of alcohol consumption and lower smoking rates may have contributed to the higher rates of adult obesity in the U.S during the COVID-19 pandemic | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, U.S. Gov't, Non-P.H.S. | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of preventive medicine |d 1987 |g 63(2022), 1 vom: 20. Juli, Seite 102-106 |w (DE-627)NLM01367370X |x 1873-2607 |7 nnns |
| 773 | 1 | 8 | |g volume:63 |g year:2022 |g number:1 |g day:20 |g month:07 |g pages:102-106 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.amepre.2022.01.012 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 63 |j 2022 |e 1 |b 20 |c 07 |h 102-106 | ||